Mushala, Bellina Aulira Skye
(2024)
Exploring the Cardioprotective Role of Adropin-GPR19 Signaling in Diabetic Cardiomyopathy.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
Diabetic cardiomyopathy (DCM) represents a distinct and increasingly prevalent complication of diabetes mellitus, characterized by structural and functional cardiac abnormalities independent of traditional cardiovascular risk factors. Diabetic cardiomyopathy features striking changes in cardiomyocyte fuel metabolism, which promote the transition into an advanced pathological state. Alterations in fuel metabolism include an increased reliance on fatty acid oxidation for mechanical energy production, at the expense of other substrates such as glucose. The resultant loss of metabolic flexibility can lead to reduced cardiac work efficiency and contractile dysfunction. The cellular mechanisms that drive changes in fuel substrate utilization are not fully understood, and this deficiency represents a major impediment to the development of novel treatments. This thesis explores the intricate mechanisms underlying DCM, focusing on the role of adropin-GPR19 signaling. Adropin, a novel peptide hormone, has emerged as a potential regulator of metabolic and cardiovascular health, while GPR19, its putative receptor, is implicated in mediating various physiological responses. We hypothesized that adropin-GPR19 signaling mediates the regulation of cardiac substrate use to reverse energy metabolism deficits and improve functional output in the diabetic heart. This research leverages a combination/series of in vivo and ex vivo metabolic approaches, utilizing knockout mutagenesis and pre-clinical animal models of DCM, to investigate the effects of adropin-GPR19 signaling on cardiac function, structure, and metabolic pathways. Results from this thesis demonstrate the potential therapeutic relevance of adropin in DCM, revealing its capacity to modulate cardiac metabolic flexibility, structural remodeling, and contractile function. Moreover, sex-dependent differences in adropin-GPR19 signaling were observed, providing novel insights into the complex interplay between metabolic derangements and cardiac dysfunction in male and female mice. The findings of this thesis shed light on the multifaceted nature of DCM, highlighting the significance of adropin-GPR19 signaling in cardiac pathophysiology. As such, these insights have promising implications for the development of novel therapeutic strategies targeting metabolic and cardiovascular dysfunction in diabetic patients. Collectively, the data presented in this thesis advances our understanding of DCM, and contributes to the ongoing efforts to mitigate its detrimental effects by highlighting the cardioprotective role of adropin-GPR19 signaling, and thus its therapeutic potential for clinical applications.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
16 September 2024 |
Date Type: |
Publication |
Defense Date: |
6 December 2023 |
Approval Date: |
16 September 2024 |
Submission Date: |
14 December 2023 |
Access Restriction: |
2 year -- Restrict access to University of Pittsburgh for a period of 2 years. |
Number of Pages: |
126 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Molecular Pharmacology |
Degree: |
PhD - Doctor of Philosophy |
Thesis Type: |
Doctoral Dissertation |
Refereed: |
Yes |
Uncontrolled Keywords: |
cardiovascular disease, mitochondrial metabolism, heart failure, peptide hormones, signal transduction, obesity, G-protein coupled receptor, novel strategies, pre-clinical animal models |
Date Deposited: |
16 Sep 2024 18:55 |
Last Modified: |
16 Sep 2024 18:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/45683 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |